Apollon Wealth Management’s Cellebrite CLBT Stock Holding History
Bought
Maintained
Sold
Other funds holding CLBT
Apollon Wealth Management's CLBT Position: Q3 2026 in Review
Apollon Wealth Management reduced its Cellebrite (CLBT) stake by 39% in Q3 2026, selling an estimated $1.2M and leaving 138,227 shares worth $1.56M. The position accounts for 0.02% of the portfolio, ranked #571.
Apollon Wealth Management first reported a position in CLBT in Q2 2026 and has held it in 2 quarters since. The position peaked at $3.33M in Q2 2026. 197 funds tracked by Wall St. Rank hold CLBT as of Q3 2026.
- Apollon Wealth Management held 138,227 shares of Cellebrite worth $1.56M as of Q3 2026.
- Apollon Wealth Management sold 89,946 Cellebrite shares in Q3 2026, an estimated $1.2M.
- Cellebrite made up 0.02% of Apollon Wealth Management's portfolio in Q3 2026, its #571 holding.
- Apollon Wealth Management first reported a position in Cellebrite in Q2 2026 and has held it in 2 quarters since.
- Apollon Wealth Management's Cellebrite position peaked at $3.33M in Q2 2026.
- 197 funds tracked by Wall St. Rank held Cellebrite as of Q3 2026.
Based on Apollon Wealth Management's 13F filing for Q3 2026, filed 23 Oct 2026.